Wiley Rein Scores WilmerHale FDA Policy Guru

Law360, New York (February 17, 2009, 12:00 AM EST) -- Wiley Rein LLP has wooed Hatch-Waxman Amendment expert James N. Czaban, former co-chair of WilmerHale LLP’s FDA group, to its Washington, D.C., office as a partner in its food, drug and product safety practice.

Czaban told Law360 that he chose Wiley Rein because it is “a very sophisticated Washington-oriented firm” with a well-established history of taking on “cutting-edge FDA related work.”

Czaban’s practice emphasizes the interrelated legal, regulatory and policy issues stemming from competitive pressures within the pharmaceutical industry.

In addition to product development and promotional...
To view the full article, register now.